Cetuximab in first-line treatment of metastatic colorectal cancer in a real-life setting: Preliminary results of the EREBUS cohort.

被引：0
|
作者：
Smith, Denis
Rouyer, Magali
Mitry, Emmanuel
Monnereau, Alain
Cunha, Antonio Sa
Bignon, Emmanuelle
Le Monies, Alise
Jove, Jeremy
Noize, P.
Moore, Nicholas
Fourrier-Reglat, Annie
机构：
[1] Univ Hosp, Med Oncol, Bordeaux, France
[2] Univ V Segalen, Serv Pharmacol, Bordeaux, France
[3] Inst Curie, St Cloud, France
[4] Inst Bergonie, Bordeaux, France
[5] Chirurg Digest Hop Haut Leveque, Pessac, France
[6] Univ Bordeaux, Serv Pharmacol, Bordeaux, France
[7] Serv Pharmacol, Bordeaux, France
[8] Univ Victor Segalen, Bordeaux, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.621
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
621
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
    Rouyer, Magali
    Francois, Eric
    Cunha, Antonio Sa
    Monnereau, Alain
    Noize, Pernelle
    Robinson, Philip
    Droz-Perroteau, Cecile
    de Sagazan, Alise Le Monies
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    Fourrier-Reglat, Annie
    Smith, Denis
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : 129 - 139
  • [2] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
    Annie Fourrier-Réglat
    Denis Smith
    Magali Rouyer
    Jacques Bénichou
    Rosine Guimbaud
    Yves Bécouarn
    Olivier Bernard
    Pernelle Noize
    Nicholas Moore
    Alain Ravaud
    Targeted Oncology, 2014, 9 : 311 - 319
  • [3] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
    Fourrier-Reglat, Annie
    Smith, Denis
    Rouyer, Magali
    Benichou, Jacques
    Guimbaud, Rosine
    Becouarn, Yves
    Bernard, Olivier
    Noize, Pernelle
    Moore, Nicholas
    Ravaud, Alain
    TARGETED ONCOLOGY, 2014, 9 (04) : 311 - 319
  • [4] Effectiveness and Safety of Cetuximab as First-line Treatment in the Elderly with Metastatic Colorectal Cancer from the EREBUS Cohort
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Rouyer, Magali
    Smith, Denis
    Francois, Eric
    Monnereau, Alain
    Balestra, Aurelie
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 310 - 310
  • [5] Use of cetuximab in a real-life setting in France with respect to KRAS status - preliminary results of EREBUS cohort study
    Fourrier-Reglat, A.
    Smith, D.
    Rouyer, M.
    Francois, E.
    Mitry, E.
    Monnereau, A.
    Cunha, A. Sa
    Bignon, E.
    Le Monies, A.
    Jove, J.
    Noize, P.
    Moore, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 42 - 42
  • [6] Real-life use of cetuximab as 1st-line treatment of metastatic colorectal cancer in France: evaluation of the conformity with SmPC and guidelines - results of the EREBUS cohort study
    Rouyer, M.
    Fourrier-Reglat, A.
    Mitry, E.
    Francois, E.
    Bignon, E.
    De Sagazan, A. Le Monies
    Jove, J.
    Moore, N.
    Noize, P.
    Smith, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 104 - 105
  • [7] Real-life use of cetuximab as 1st-line treatment of metastatic colorectal cancer in France: evaluation of the conformity with SmPC and guidelines - results of the EREBUS cohort study
    Rouyer, M.
    Fourrier-Reglat, A.
    Mitry, E.
    Francois, E.
    Bignon, E.
    de Sagazan, A. L. E. Monies
    Jove, J.
    Moore, N.
    Noize, P.
    Smith, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 25 - 25
  • [8] CETUXIMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A433 - A434
  • [9] Cetuximab for the first-line treatment of metastatic colorectal cancer
    Meads, C.
    Round, J.
    Tubeuf, S.
    Moore, D.
    Pennant, M.
    Baylis, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 8
  • [10] Surgical resection of liver metastases and survival outcomes in real-life for metastatic colorectal cancer (mCRC) patients treated in front-line with cetuximab (CTX): The EREBUS cohort.
    Smith, Denis Michel
    Cunha, Antonio Sa
    Rouyer, Magali
    Noize, Pernelle
    Jove, Jeremy
    Bignon, Emmanuelle
    Le Monies, Alise
    Mitry, Emmanuel
    Francois, Eric
    Fourrier-Reglat, Annie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345